vs
Acadia Healthcare Company, Inc.（ACHC）与MSC INDUSTRIAL DIRECT CO INC（MSM）财务数据对比。点击上方公司名可切换其他公司
MSC INDUSTRIAL DIRECT CO INC的季度营收约是Acadia Healthcare Company, Inc.的1.2倍（$965.7M vs $829.0M），MSC INDUSTRIAL DIRECT CO INC净利率更高（5.4% vs 0.5%，领先4.8%），Acadia Healthcare Company, Inc.同比增速更快（7.5% vs 4.0%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
MSC工业直销公司（MSC）通过旗下主要子公司MSC工业供应公司，是美国规模最大的工业设备分销商之一，可提供超过150万种金属加工及其他工业类产品，广泛服务于工业制造、维修运维等领域的客户需求。
ACHC vs MSM — 直观对比
营收规模更大
MSM
是对方的1.2倍
$829.0M
营收增速更快
ACHC
高出3.5%
4.0%
净利率更高
MSM
高出4.8%
0.5%
两年增速更快
ACHC
近两年复合增速
-3.4%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $965.7M |
| 净利润 | $4.5M | $51.8M |
| 毛利率 | — | 40.7% |
| 营业利润率 | — | 7.9% |
| 净利率 | 0.5% | 5.4% |
| 营收同比 | 7.5% | 4.0% |
| 净利润同比 | -50.8% | 11.1% |
| 每股收益（稀释后） | $0.05 | $0.93 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCMSM
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $965.7M | ||
| Q3 25 | $851.6M | $978.2M | ||
| Q2 25 | $869.2M | $971.1M | ||
| Q1 25 | $770.5M | — | ||
| Q4 24 | $774.2M | $928.5M | ||
| Q3 24 | $815.6M | — | ||
| Q2 24 | $796.0M | $979.4M |
净利润ACHCMSM
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $51.8M | ||
| Q3 25 | $36.2M | $56.5M | ||
| Q2 25 | $30.1M | $56.8M | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $32.6M | $46.6M | ||
| Q3 24 | $68.1M | — | ||
| Q2 24 | $78.5M | $71.7M |
毛利率ACHCMSM
| Q1 26 | — | — | ||
| Q4 25 | — | 40.7% | ||
| Q3 25 | — | 40.4% | ||
| Q2 25 | — | 41.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 40.9% |
营业利润率ACHCMSM
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 7.9% | ||
| Q3 25 | 4.7% | 8.6% | ||
| Q2 25 | 5.8% | 8.5% | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | 7.8% | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 13.4% | 10.9% |
净利率ACHCMSM
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 5.4% | ||
| Q3 25 | 4.3% | 5.8% | ||
| Q2 25 | 3.5% | 5.9% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 4.2% | 5.0% | ||
| Q3 24 | 8.4% | — | ||
| Q2 24 | 9.9% | 7.3% |
每股收益（稀释后）ACHCMSM
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.93 | ||
| Q3 25 | $0.40 | $1.02 | ||
| Q2 25 | $0.33 | $1.02 | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.36 | $0.83 | ||
| Q3 24 | $0.74 | — | ||
| Q2 24 | $0.85 | $1.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $40.3M |
| 总债务越低越好 | $2.5B | $214.1M |
| 股东权益账面价值 | $2.0B | $1.4B |
| 总资产 | $5.5B | $2.5B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资ACHCMSM
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $40.3M | ||
| Q3 25 | $118.7M | $56.2M | ||
| Q2 25 | $131.4M | $71.7M | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | $57.3M | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | $25.9M |
总债务ACHCMSM
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $214.1M | ||
| Q3 25 | $2.3B | $168.8M | ||
| Q2 25 | $2.3B | $285.0M | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | $289.9M | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | $299.8M |
股东权益ACHCMSM
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $3.1B | $1.4B | ||
| Q2 25 | $3.1B | $1.4B | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.1B | $1.4B | ||
| Q3 24 | $3.0B | — | ||
| Q2 24 | $3.0B | $1.4B |
总资产ACHCMSM
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.5B | ||
| Q3 25 | $6.4B | $2.5B | ||
| Q2 25 | $6.3B | $2.5B | ||
| Q1 25 | $6.1B | — | ||
| Q4 24 | $6.0B | $2.5B | ||
| Q3 24 | $5.9B | — | ||
| Q2 24 | $5.7B | $2.5B |
负债/权益比ACHCMSM
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.16× | ||
| Q3 25 | 0.74× | 0.12× | ||
| Q2 25 | 0.74× | 0.21× | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | 0.21× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $29.4M |
| 自由现金流经营现金流 - 资本支出 | — | $7.4M |
| 自由现金流率自由现金流/营收 | — | 0.8% |
| 资本支出强度资本支出/营收 | — | 2.3% |
| 现金转化率经营现金流/净利润 | 13.78× | 0.57× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCMSM
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $29.4M | ||
| Q3 25 | $73.2M | — | ||
| Q2 25 | $133.5M | $151.6M | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $116.7M | $101.9M | ||
| Q3 24 | $163.1M | — | ||
| Q2 24 | $171.1M | $143.5M |
自由现金流ACHCMSM
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $7.4M | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | $100.7M | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | $81.7M | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | $114.0M |
自由现金流率ACHCMSM
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 0.8% | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | 10.4% | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | 8.8% | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | 11.6% |
资本支出强度ACHCMSM
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.3% | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | 5.2% | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | 2.2% | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | 3.0% |
现金转化率ACHCMSM
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 0.57× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | 2.67× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 2.18× | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | 2.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
MSM
暂无分部数据
